These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20117665)

  • 61. Production of medical radionuclides in Russia: status and future--a review.
    Zhuikov BL
    Appl Radiat Isot; 2014 Feb; 84():48-56. PubMed ID: 24315977
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RADIOISOTOPE SCANNING IN THE DIAGNOSIS OF LIVER DISEASE.
    SORENSEN LB
    Biochem Clin; 1964; 3():47-53. PubMed ID: 14270169
    [No Abstract]   [Full Text] [Related]  

  • 63. VISUALIZATION OF THE LIVER BY SCANNING WITH MO99 (MOLYBDATE) AS TRACER.
    SORENSEN LB; ARCHAMBAULT M
    J Lab Clin Med; 1963 Aug; 62():330-40. PubMed ID: 14057883
    [No Abstract]   [Full Text] [Related]  

  • 64. Reduction of radioactive impurities in radiopharmaceuticals.
    Barrall RC; Bowen BM; Wood DE
    J Nucl Med; 1972 Jul; 13(7):570-1. PubMed ID: 5033917
    [No Abstract]   [Full Text] [Related]  

  • 65. Technetium-99m: basic nuclear physics and chemical properties.
    Castronovo FP
    Am J Hosp Pharm; 1975 May; 32(5):480-8. PubMed ID: 238387
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nuclear medicine affected by Energy Policy Act of 2005.
    J Nucl Med; 2005 Oct; 46(10):12N, 14N. PubMed ID: 16312055
    [No Abstract]   [Full Text] [Related]  

  • 67. Global contrast in nuclear medicine.
    Currie GM; Kiat H; Wheat JM
    J Nucl Med Technol; 2010 Sep; 38(3):115-6. PubMed ID: 20807852
    [No Abstract]   [Full Text] [Related]  

  • 68. Radioisotope (99 Mo) study of the kinetics of molybdenum clearence from the blood and of the role of blood components.
    Kselíková M; Bíbr B; Lener J
    Physiol Bohemoslov; 1974; 23(1):83-8. PubMed ID: 4280582
    [No Abstract]   [Full Text] [Related]  

  • 69. [Commentary on the guidelines for clinical evaluation of diagnostic radiopharmaceuticals by the Japanese Society of Nuclear Medicine (3). The draft of the guidelines by the Japanese Society of Nuclear Medicine].
    Sasada H; Onishi Y
    Kaku Igaku; 2010 May; 47(2):145-52. PubMed ID: 22462154
    [No Abstract]   [Full Text] [Related]  

  • 70. 186Re and high-specific-activity 177Lu available in North America.
    J Nucl Med; 2004 Apr; 45(4):22N. PubMed ID: 15073239
    [No Abstract]   [Full Text] [Related]  

  • 71. Lessons from the Tc-99m shortage: implications of substituting Tl-201 for Tc-99m single-photon emission computed tomography.
    Small GR; Ruddy TD; Simion O; Alam M; Fuller L; Chen L; Beanlands RS; Chow BJ
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):683-91. PubMed ID: 23873401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sodium sulfate as an eluant for concentrated solution of pertechnetate.
    Mushtaq A; Haider I
    Appl Radiat Isot; 2008 Aug; 66(8):1079-82. PubMed ID: 18280744
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molybdenum target specifications for cyclotron production of 99mTc based on patient dose estimates.
    Hou X; Tanguay J; Buckley K; Schaffer P; Bénard F; Ruth TJ; Celler A
    Phys Med Biol; 2016 Jan; 61(2):542-53. PubMed ID: 26683410
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nuclear pharmacists cope with isotope shortage.
    Traynor K
    Am J Health Syst Pharm; 2010 Jul; 67(14):1132-4. PubMed ID: 20592311
    [No Abstract]   [Full Text] [Related]  

  • 75. SNMMI Leadership Update: An Exciting Time for Nuclear Medicine and Molecular Imaging.
    Schwarz SW
    J Nucl Med; 2017 Jun; 58(6):19N. PubMed ID: 28572297
    [No Abstract]   [Full Text] [Related]  

  • 76. Energy Department molybdenum plan faltering.
    J Nucl Med; 1993 Apr; 34(4):20N. PubMed ID: 8455070
    [No Abstract]   [Full Text] [Related]  

  • 77. A preliminary study for the production of high specific activity radionuclides for nuclear medicine obtained with the isotope separation on line technique.
    Borgna F; Ballan M; Corradetti S; Vettorato E; Monetti A; Rossignoli M; Manzolaro M; Scarpa D; Mazzi U; Realdon N; Andrighetto A
    Appl Radiat Isot; 2017 Sep; 127():214-226. PubMed ID: 28649019
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quality control of 99Mo/99Tcm generators: results of a survey of the Radiopharmacy Working Group of the Italian Association of Nuclear Medicine (AIMN).
    Marengo M; Aprile C; Bagnara C; Bolzati C; Bonada C; Candini G; Casati R; Civollani S; Colombo FR; Compagnone G; Del Dottore F; Di Guglielmo E; Ferretti PP; Lazzari S; Minoia C; Pancaldi D; Ronchi A; Sanità di Toppi G; Saponaro R; Torregiani T; Uccelli L; Vecchi F; Piffanelli A
    Nucl Med Commun; 1999 Nov; 20(11):1077-84. PubMed ID: 10572919
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Commentary on the guidelines for clinical evaluation of diagnostic radiopharmaceuticals by the Japanese Society of Nuclear Medicine (2). The guidance on development of radiopharmaceuticals for diagnostic imagings in the United States and Europe].
    Sasada H; Onishi Y
    Kaku Igaku; 2010 May; 47(2):81-144. PubMed ID: 22457910
    [No Abstract]   [Full Text] [Related]  

  • 80. [The Gordian Knot 2.0 - Decentralized production of radiopharmaceuticals].
    Burchert W; Hugenberg V
    Nuklearmedizin; 2019 Dec; 58(6):420-423. PubMed ID: 31794976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.